Profil
Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd. and the General Manager at CtM Bio Co., Ltd. Prior to these roles, Dr. Fang worked as the Director of Research & Development at I-MAB Biopharma Co., Ltd. from 2016 to 2020.
Dr. Fang also served as a Director at Third Venture Biopharma (Nanjing) Co., Ltd. Dr. Fang holds a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University, which was conferred in 2004.
Aktiva positioner av Lei Fang
| Företag | Position | Start |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Företagsledare/Principal | 2020-12-10 |
CtM Bio Co., Ltd. | Verkställande Direktör | - |
Tidigare kända positioner av Lei Fang
| Företag | Position | Slut |
|---|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Teknisk/Vetenskaplig/F&U Direktör | 2020-04-01 |
Third Venture Biopharma (Nanjing) Co., Ltd. | Direktör/Styrelseledamot | - |
Lei Fangs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Chinese Academy of Sciences
Chinese Academy of Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hebei University
Hebei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
CtM Bio Co., Ltd. | |
Third Venture Biopharma (Nanjing) Co., Ltd. |
















